Brought to you by:
SCVS 2023: DAPT shows higher survival rate in patients with low WIfI scores, study indicates
A retrospective cohort study presented at the 2023 Society for Clinical Vascular Surgery (SCVS) Annual Symposium in Miami (March 25–29) has found lower-extremity bypass patients who received dual antiplatelet therapy or anticoagulation (DAPT/AC) postoperatively had a higher 30-day survival rate.…
SCVS 2023: Endovascular-first or -only approach to all CLTI patients ‘is not evidence-based care’
Michael S. Conte, MD, one of the foremost experts in the field of peripheral arterial disease (PAD), took attendees of the 2023 annual meeting of the Society for Clinical Vascular Surgery (SCVS) in Miami on a journey through the decades…
SCVS 2023: Four decades of AAAs in the US: Rare epidemiological study establishes women are diagnosed and repaired 10 years later than men
Abdominal aortic aneurysm (AAA) diagnosis and repair occurs among women almost 10 years later than in men—with similar age-adjusted mortality—the 2023 Society for Clinical Vascular Surgery (SCVS) annual meeting in Miami (March 25–29) is set to be told. The finding…
The year in review: 2022 was an amazing 12 months for SVS
Despite any number of challenges, the Society for Vascular Surgery (SVS) had a hugely successful 2022 and looks forward to a bright 2023. Executive Director Kenneth M. Slaw, PhD, outlined a number of firsts for the Society, including: The year…
SVS vascular leaders: Cohort four of Leadership Development Program selected
Twenty-nine people have been selected for development as future leaders of the profession and the Society for Vascular Surgery (SVS). They represent cohort four of the Leadership Development Program (LDP), a nine-month-long interactive course designed to help them reach their…
BEST-CLI attracts $3.3m funding injection to continue data analysis
The Novo Nordisk Foundation has made a $3.3 million contribution toward the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb ischemia) clinical trial, the Denmark-based entity has announced. The grant is set to be used by investigators…
Leadership program applications due by Aug. 15
Learn to be a leader or enhance your leadership skills—applications to be part of the fourth cohort of the Society for Vascular Surgery (SVS) Leadership Development Program (LDP) are due Aug. 15. The year-long, highly interactive learning experience is recommended…
Female sex is associated with reintervention and mortality following elective EVAR
Women are more likely to die within five years of having elective surgery to repair an abdominal aortic aneurysm (AAA) or need repeat surgery, according to a recent study. Writing in the Journal of Vascular Surgery, Taylor Corsi, BS, a medical student at Rutgers University, Piscataway,…
Bolstering the workforce: Session details how to start a vascular training program
The workforce shortage issues set to plague vascular surgery over the next few decades, alongside an aging population and increase in vascular disease, formed the backdrop to a 2022 Vascular Annual Meeting (VAM) breakout session in Boston (June 15–18) designed…
Tissue samples show paclitaxel effect in minority of CLTI patients receiving DCB angioplasty, study finds
Paclitaxel effect was witnessed in tissue specimens of a minority of chronic limb-threatening ischemia (CLTI) patients treated with drug-coated balloons (DCBs)—but was not dependent on DCB type, nor the dose level of the drug administered, and was not associated with…